prevalence

  1. Trish

    Estimating Prevalence, Demographics and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning, 2018, Valdez, Proskauer et al

    Estimating Prevalence, Demographics and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning Ashley Valdez, Elizabeth E. Hancock, Seyi Adebayo, David Kiernicki, Daniel Proskauer, John R. Attewell, Lucinda Bateman, Alfred DeMaria Jr, Charles W. Lapp5, Peter C. Rowe and...
    • Trish
    • Thread
    • bateman epidemiology gender ratio lapp machine learning me/cfs prevalence proskauer rowe valdez
    • Replies: 53
    • Forum: ME/CFS research
  2. John Mac

    Defining the prevalence and symptom burden of those with self-reported severe CFS/ME: a ... community pilot study... (2017) Strassheim et al

    https://bmjopen.bmj.com/content/8/9/e020775
  3. John Mac

    Prevalence and incidence of ME/CFS in Europe—the Euro-epiME study from the European network EUROMENE, 2018, Estevez-Lopez et al

    Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review https://bmjopen.bmj.com/content/8/9/e020817
    • John Mac
    • Thread
    • 2018 epidemiology estevez-lopez euromene me/cfs paper prevalence protocol review
    • Replies: 2
    • Forum: ME/CFS research
  4. Dolphin

    Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome

    https://link.springer.com/article/10.1007%2Fs10096-018-3265-z Eur J Clin Microbiol Infect Dis. 2018 May 26. doi: 10.1007/s10096-018-3265-z. [Epub ahead of print] Interferon-γ and CXCL10 responses related to complaints in patients with Q fever fatigue syndrome. Raijmakers RPH1,2, Jansen AFM3,4...
    • Dolphin
    • Thread
    • cxcl10 cxcl11 cxcl9 fatigue ifny il-2 immunology interferon interferon-y me/cfs prevalence q fever q fever fatigue syndrome raijmakers van der meer
    • Replies: 2
    • Forum: ME/CFS research
  5. Dr Carrot

    How do we make sure ME prevelance numbers are as accurate as possible?

    Have been thinking about this a fair bit recently. One of the most common forms of advocacy with this illness is stressing how debilitating it is, but also how common, citing a greater prevelance than say, MS. However, it’s difficult to know how accurate our numbers really are with this. I...
Back
Top Bottom